101 related articles for article (PubMed ID: 10781845)
21. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
22. Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain.
Bilska A; Dubiel M; Sokołowska-Jezewicz M; Lorenc-Koci E; Włodek L
Neuroscience; 2007 Jun; 146(4):1758-71. PubMed ID: 17478054
[TBL] [Abstract][Full Text] [Related]
23. Energetic dysfunction in quinolinic acid-lesioned rat striatum.
Bordelon YM; Chesselet MF; Nelson D; Welsh F; Erecińska M
J Neurochem; 1997 Oct; 69(4):1629-39. PubMed ID: 9326292
[TBL] [Abstract][Full Text] [Related]
24. Cerebral cortex, hippocampus, striatum and cerebellum show differential susceptibility to quinolinic acid-induced oxidative stress.
Vandresen-Filho S; Martins WC; Bertoldo DB; Mancini G; De Bem AF; Tasca CI
Neurol Sci; 2015 Aug; 36(8):1449-56. PubMed ID: 25805706
[TBL] [Abstract][Full Text] [Related]
25. [Short-term effects of septo-hippocampal pathway transsection and cerebrolysin effects on glutathione-related enzymes in the rat brain].
Cruz R; Francis L; Díaz-Suárez CM; González-Fraguela ME
Rev Neurol; 1998 Apr; 26(152):551-4. PubMed ID: 9796003
[TBL] [Abstract][Full Text] [Related]
26. Striatal implants of fetal striatum or gelfoam protect against quinolinic acid lesions of the striatum.
Pearlman S; Levivier M; Gash DM
Brain Res; 1993 Jun; 613(2):203-11. PubMed ID: 8186968
[TBL] [Abstract][Full Text] [Related]
27. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum.
Qin ZH; Wang Y; Chen RW; Wang X; Ren M; Chuang DM; Chase TN
J Pharmacol Exp Ther; 2001 Apr; 297(1):78-87. PubMed ID: 11259530
[TBL] [Abstract][Full Text] [Related]
29. RETRACTED: Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity.
Carmona-Ramírez I; Santamaría A; Tobón-Velasco JC; Orozco-Ibarra M; González-Herrera IG; Pedraza-Chaverrí J; Maldonado PD
J Nutr Biochem; 2013 Jan; 24(1):14-24. PubMed ID: 22704781
[TBL] [Abstract][Full Text] [Related]
30. Visual evoked potentials in the rat quinolinic acid model of Huntington's disease.
Schwarz M; Block F
Neurosci Lett; 1993 Apr; 152(1-2):81-3. PubMed ID: 8390629
[TBL] [Abstract][Full Text] [Related]
31. In vivo intracerebral administration of L-2-hydroxyglutaric acid provokes oxidative stress and histopathological alterations in striatum and cerebellum of adolescent rats.
da Rosa MS; João Ribeiro CA; Seminotti B; Teixeira Ribeiro R; Amaral AU; Coelho Dde M; de Oliveira FH; Leipnitz G; Wajner M
Free Radic Biol Med; 2015 Jun; 83():201-13. PubMed ID: 25701435
[TBL] [Abstract][Full Text] [Related]
32. Methionine and cysteine affect glutathione level, glutathione-related enzyme activities and the expression of glutathione S-transferase isozymes in rat hepatocytes.
Wang ST; Chen HW; Sheen LY; Lii CK
J Nutr; 1997 Nov; 127(11):2135-41. PubMed ID: 9372907
[TBL] [Abstract][Full Text] [Related]
33. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
[TBL] [Abstract][Full Text] [Related]
34. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
35. Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats.
Ribeiro CA; Grando V; Dutra Filho CS; Wannmacher CM; Wajner M
J Neurochem; 2006 Dec; 99(6):1531-42. PubMed ID: 17230642
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies.
Santamaría A; Salvatierra-Sánchez R; Vázquez-Román B; Santiago-López D; Villeda-Hernández J; Galván-Arzate S; Jiménez-Capdeville ME; Ali SF
J Neurochem; 2003 Jul; 86(2):479-88. PubMed ID: 12871589
[TBL] [Abstract][Full Text] [Related]
37. Protective role of glutathione reductase in paraquat induced neurotoxicity.
Djukic MM; Jovanovic MD; Ninkovic M; Stevanovic I; Ilic K; Curcic M; Vekic J
Chem Biol Interact; 2012 Aug; 199(2):74-86. PubMed ID: 22721943
[TBL] [Abstract][Full Text] [Related]
38. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
Bordelon YM; Chesselet MF
Neuroscience; 1999; 93(3):843-53. PubMed ID: 10473250
[TBL] [Abstract][Full Text] [Related]
39. Restraint stress-induced oxidative damage and its amelioration with selenium.
Atif F; Yousuf S; Agrawal SK
Eur J Pharmacol; 2008 Dec; 600(1-3):59-63. PubMed ID: 18854182
[TBL] [Abstract][Full Text] [Related]
40. NMDA receptor overstimulation triggers a prolonged wave of immediate early gene expression: relationship to excitotoxicity.
Shan Y; Carlock LR; Walker PD
Exp Neurol; 1997 Apr; 144(2):406-15. PubMed ID: 9168840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
